OptiBiotix Health (LON:OPTI) Stock Price Up 9.6% – Time to Buy?

OptiBiotix Health Plc (LON:OPTI)’s stock price rose 9.6% during mid-day trading on Thursday . The company traded as high as GBX 6.50 and last traded at GBX 6.30. Approximately 597,335 shares traded hands during trading, an increase of 26% from the average daily volume of 473,704 shares. The stock had previously closed at GBX 5.75.

OptiBiotix Health Stock Down 0.7%

The stock has a market cap of £6.26 million, a PE ratio of -202.00 and a beta of 1.71. The company has a fifty day moving average price of GBX 5.31 and a 200 day moving average price of GBX 6.35.

OptiBiotix Health (LON:OPTI) last released its quarterly earnings data on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.The company had revenue of GBX 117 million during the quarter.

Insider Activity at OptiBiotix Health

In other news, insider David Blain acquired 158,965 shares of the stock in a transaction dated Thursday, May 28th. The stock was purchased at an average cost of GBX 6 per share, with a total value of £9,537.90. Company insiders own 26.82% of the company’s stock.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.